Clarivate PLC: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Clarivate PLC Unternehmen

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.

Unternehmensinformationen

BörsenkürzelCLVT

Name des UnternehmensClarivate PLC

IPO-datumOct 29, 2018

Gegründet am2019

CEOMr. Matitiahu Shem (Matti) Tov

Anzahl der mitarbeiter12000

WertpapierartOrdinary Share

GeschäftsjahresendeOct 29

Addresse70 St. Mary Axe

StadtLONDON

BörseNYSE Consolidated

LandUnited Kingdom

PostleitzahlEC3A 8BE

Telefon442074334000

Websitehttps://clarivate.com/

BörsenkürzelCLVT

IPO-datumOct 29, 2018

Gegründet am2019

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

411.80K

-8.81%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Mr. Jane Okun Bomba, CPA

Independent Director

--

Ms. Suzanne Heywood

Independent Director

--

Mr. Usama N. Cortas

Independent Director

--

Mr. Mark Donohue

Vice President - Investor Relations

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

488.98K

+10.04%

Mr. Henry Levy

President - Life Sciences and Health care

411.80K

-8.81%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Subscription revenues

1.63B

63.63%

Transactional revenues

500.10M

19.56%

Re-occurring revenues

429.80M

16.81%

Nach RegionUSD

Name

Umsatz

Anteil

Americas

1.38B

54.03%

Europe/ Middle East /Africa

667.80M

26.12%

Asia Pacific

507.50M

19.85%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Subscription revenues

1.63B

63.63%

Transactional revenues

500.10M

19.56%

Re-occurring revenues

429.80M

16.81%

Aktionärsstatistik

Aktualisiert: Sat, May 17

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Leonard Green & Partners, L.P.

17.08%

Clarkston Capital Partners, LLC

10.91%

Giovanni Agnelli B V

9.85%

Impactive Capital LP

6.30%

Onex Corporation

6.14%

Other

49.72%

Aktionäre

Anteil

Leonard Green & Partners, L.P.

17.08%

Clarkston Capital Partners, LLC

10.91%

Giovanni Agnelli B V

9.85%

Impactive Capital LP

6.30%

Onex Corporation

6.14%

Other

49.72%

Aktionärstypen

Aktionäre

Anteil

Private Equity

30.46%

Investment Advisor

28.17%

Investment Advisor/Hedge Fund

15.54%

Hedge Fund

14.68%

Holding Company

9.85%

Corporation

5.58%

Pension Fund

1.73%

Individual Investor

1.04%

Sovereign Wealth Fund

0.85%

Institutionelle Beteiligung

Aktualisiert: Sat, Feb 22

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q1

677

774.53M

113.38%

-133.10M

2024Q4

712

766.77M

110.84%

-166.20M

2024Q3

726

765.53M

108.25%

-158.23M

2024Q2

741

760.08M

105.78%

-120.39M

2024Q1

752

730.14M

108.67%

-137.39M

2023Q4

783

725.50M

108.90%

-179.38M

2023Q3

791

741.16M

111.25%

-79.71M

2023Q2

796

712.25M

105.35%

-100.17M

2023Q1

777

702.68M

104.01%

-43.46M

2022Q4

788

663.31M

98.18%

-69.01M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Leonard Green & Partners, L.P.

116.67M

16.93%

--

Dec 31, 2024

Clarkston Capital Partners, LLC

70.73M

10.27%

-1.48M

-2.04%

Dec 31, 2024

Giovanni Agnelli B V

67.29M

9.77%

--

Dec 31, 2024

Impactive Capital LP

43.03M

6.25%

+3.40M

+8.58%

Dec 31, 2024

Onex Corporation

42.86M

6.22%

--

Mar 15, 2024

Selige Co-Investor Pooling SCSp

38.09M

5.53%

--

Mar 15, 2024

Partners Group AG

25.58M

3.71%

--

Dec 31, 2024

Cambridge Information Group, Inc.

23.61M

3.43%

--

Mar 15, 2024

Dimensional Fund Advisors, L.P.

14.46M

2.1%

-38.61K

-0.27%

Dec 31, 2024

Fidelity Investments Canada ULC

15.29M

2.22%

-1.75M

-10.27%

Dec 31, 2024

Verbundene ETFs

Aktualisiert: Fri, Jun 6

Name

Anteil

AGF US Market Neutral Anti-Beta Fund

0.52%

First Trust Technology Alphadex

0.35%

WisdomTree US MidCap Fund

0.2%

JPMorgan US Value Factor ETF

0.19%

Avantis US Small Cap Value ETF

0.16%

John Hancock Multifactor Small Cap ETF

0.15%

Nuveen ESG Small-Cap ETF

0.15%

DFA Dimensional US Small Cap Value ETF

0.13%

T Rowe Price Small-Mid Cap ETF

0.12%

BNY Mellon US Small Cap Core Equity ETF

0.1%

AGF US Market Neutral Anti-Beta Fund

Anteil0.52%

First Trust Technology Alphadex

Anteil0.35%

WisdomTree US MidCap Fund

Anteil0.2%

JPMorgan US Value Factor ETF

Anteil0.19%

Avantis US Small Cap Value ETF

Anteil0.16%

John Hancock Multifactor Small Cap ETF

Anteil0.15%

Nuveen ESG Small-Cap ETF

Anteil0.15%

DFA Dimensional US Small Cap Value ETF

Anteil0.13%

T Rowe Price Small-Mid Cap ETF

Anteil0.12%

BNY Mellon US Small Cap Core Equity ETF

Anteil0.1%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Clarivate PLC

4.290USD

Clarivate PLC

4.290

Übersicht

Unternehmen